buflomedil has been researched along with Anemia, Sickle Cell in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bachir, D; Beuzard, Y; Galacteros, F; Kraiem, A; Maurel, A; Portos, JL; Razavian, M | 1 |
Briguglio, E; Briguglio, F; Di Marco, V | 1 |
1 trial(s) available for buflomedil and Anemia, Sickle Cell
Article | Year |
---|---|
Improvement of microcirculation abnormalities in sickle cell patients upon buflomedil treatment.
Topics: Adult; Anemia, Sickle Cell; Angioscopy; Double-Blind Method; Female; Hematologic Tests; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; Middle Aged; Pyrrolidines; Vasodilator Agents | 1993 |
1 other study(ies) available for buflomedil and Anemia, Sickle Cell
Article | Year |
---|---|
[Protective effect of buflomedil hydrochloride on erythrocyte sickling. In vitro study].
Topics: 2,3-Diphosphoglycerate; Adenosine Triphosphate; Adult; Anemia, Sickle Cell; Child; Child, Preschool; Diphosphoglyceric Acids; Erythrocytes, Abnormal; Female; Humans; Male; Middle Aged; Pyrrolidines; Vasodilator Agents | 1986 |